eess.IVOct 30, 2026

TopoHyperClinicalGraph: A Geometry and Topology-Aware Multimodal Framework for Cancer Survival Prediction

Authors: Noaman Khan, Zubair Shah

Organizations: College of Science and Engineering, Hamad Bin Khalifa University, Doha, Qatar

Abstract

We developed TopoHyperClinicalGraph, a multimodal framework combining hyperbolic tissue geometry, persistent topology and clinical graph learning for cancer survival prediction. Pre-extracted UNI2-h features are reduced from 1,536 to 1,024 dimensions using training-fold PCA. A pathology backbone combines hyperbolic neighborhoods with Lorentz-centroid attention pooling. Once frozen, its survival logits are adjusted using persistence descriptors from up to 64 landmarks per slide and sampling controls. A five-node clinical graph then learns a further correction from age, sex, stage, T and N. Five-fold patient-level evaluation covered eight TCGA and CPTAC cohorts with 2,364 patients. Mean validation-selected C-indices for TopoHyperClinicalGraph versus pathology-only spatial PatchGCN were 0.7563 versus 0.7386 in COADREAD, 0.6220 versus 0.5998 in HNSC, 0.6755 versus 0.6535 in BRCA and 0.6409 versus 0.6176 in STAD. CPTAC scores were 0.5984 in HNSC, 0.6060 in PDA, 0.8055 in CCRCC and 0.7192 in LUAD. CPTAC-HNSC used TCGA-initialized adaptation; other CPTAC backbones were trained within their cohorts. Geometry accounted for most pathology-only gains, with smaller persistence effects. Clinical graph fusion exceeded its matched node-wise control in five cohorts, tied in one and scored lower in two; clinical-only prediction exceeded fusion in three CPTAC cohorts. The framework supports separate evaluation of geometric, topological and clinical contributions. All scores were validation-selected; independent testing is needed to establish generalizability.

Figures & tables

Explore similar work

May 20, 2026

ProtoPathway: Biologically Structured Prototype-Pathway Fusion for Multimodal Cancer Survival Prediction

We introduce ProtoPathway, an interpretable-by-design multimodal framework for cancer survival prediction that unifies whole slide imaging and transcriptomics through encoders producing biologically grounded representations on both sides of the fusion. On the histopathology side, KK learnable morphological prototypes, trained end-to-end with the survival objective, serve as the slide representation itself: patches flow into prototype tokens via soft assignment, compressing variable-length patch sets into fixed task-adaptive tokens. On the genomic side, a bipartite graph neural network encodes gene expression within the Reactome pathway hierarchy, producing pathway embeddings that reflect both constituent genes and their broader biological context through bidirectional message passing over a shared gene--pathway graph. Cross-modal attention then operates over a compact prototype ×\times pathway matrix in which prototypes query pathways, modeling the biological direction in which molecular programs give rise to tissue morphology. Because both axes carry stable task-learned identity, the attention matrix is itself an interpretability output, yielding native inference-time attribution across the full biological hierarchy, from genes through pathways and prototypes to spatial tissue maps. We evaluate on five TCGA cancer cohorts, demonstrating competitive or superior survival prediction with substantially improved biological interpretability and reduced computational cost, with interpretability claims validated through fold-stratified rank-based population-level analysis. Our source code, model weights, and Reactome pathways, together with a unified codebase reimplementing all multimodal survival baselines under identical preprocessing and evaluation, are available at: https://github.com/AmayaGS/ProtoPathway.
Feb 26, 2026

Hierarchical Multi-Scale Graph Learning with Knowledge-Guided Attention for Whole-Slide Image Survival Analysis

We propose a Hierarchical Multi-scale Knowledge-aware Graph Network (HMKGN) that models multi-scale interactions and spatially hierarchical relationships within whole-slide images (WSIs) for cancer prognostication. Unlike conventional attention-based MIL, which ignores spatial organization, or graph-based MIL, which relies on static handcrafted graphs, HMKGN enforces a hierarchical structure with spatial locality constraints, wherein local cellular-level dynamic graphs aggregate spatially proximate patches within each region of interest (ROI) and a global slide-level dynamic graph integrates ROI-level features into WSI-level representations. Moreover, multi-scale integration at the ROI level combines coarse contextual features from broader views with fine-grained structural representations from local patch-graph aggregation. We evaluate HMKGN on four TCGA cohorts (KIRC, LGG, PAAD, and STAD; N=513, 487, 138, and 370) for survival prediction. It consistently outperforms existing MIL-based models, yielding improved concordance indices (10.85% better) and statistically significant stratification of patient survival risk (log-rank p < 0.05).
Jun 17, 2026

ChronoSurv: A Clinical Pathway-Guided Graph Framework for Multimodal Survival Analysis

Accurate survival prediction is essential for personalized treatment planning in head and neck cancer, yet remains challenging due to the heterogeneous and high-dimensional nature of multimodal clinical data. While deep survival models have improved predictive performance over classical statistical approaches, existing methods typically rely on static fusion strategies or temporally agnostic modeling, limiting their ability to capture structured clinical workflows. In this work, we propose ChronoSurv, a heterogeneous hierarchical directed graph framework for multimodal survival analysis. ChronoSurv represents patient care as a progression-aware clinical trajectory using directed graphs aligned with key diagnostic steps. A hierarchical topology incorporates fine-grained, coarse, and global representations, further supporting flexible adaptation to missing modalities, while heterogeneous message passing models complex and asymmetric relationships across modalities and clinical steps. Experimental results on two public datasets demonstrate that ChronoSurv achieves state-of-the-art discriminative performance while maintaining statistically reliable calibration. Comprehensive ablation studies further confirm the contribution of each architectural component, highlighting the potential of trajectory-aware graph modeling for multimodal survival prediction.